[ad_1]
For investors, the question is whether Thursday’s rotation marks the start of a broadening out of a rally that’s taken the S&P 500 and Nasdaq Composite to a series of records in 2024.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...